Can mRNA technology used in COVID-19 vaccines be used to cure cancer? – The Jerusalem Post

One of the scientists behind the Pfizer-BioNTech vaccine – the first widely approved immunization for the novel coronavirus – claims that the technology the companies utilized might be used to deal with another lethal disease – cancer.Ozlem Tureci co-founded the German business BioNTech alongside her spouse in the late 2000s. BioNTech had, for years, been developing a way to fight cancer and eliminate growths – technology which they pivoted towards beating the novel coronavirus.The Pfizer-BioNTech vaccine, called BNT162b2, is based on messenger RNA (mRNA) technology, which utilizes a chemical messenger to instruct cells to make proteins that mimic the external surface area of the brand-new coronavirus, thus creating immunity. There has actually been a clear air of vaccine hesitancy – the reluctance or rejection to be vaccinated – amid world populations, Teluci noted to AP that “no corners were cut” nor stone left unturned while racing to establish a vaccine.”As Teluci noted, the success of COVID-19 vaccines based off of mRNA is smoothing the way for utilizing the unique innovation not just in other vaccines, but potentially as treatments for cystic fibrosis, cancer and other hard-to-treat diseases.Both of the vaccines utilized by Pfizer-BioNTech and Moderna rely on mRNA technology.Scientists say mRNA has the potential to target diseases that can not be reached by standard drugs.The technology is often likened to the operating system on a computer, allowing drugmakers to modify their target by placing new genetic code into a manufactured kind of mRNA, a natural chemical messenger that advises the body to produce specific proteins.Its advantage in vaccines is versatility and speed compared to standard technology requiring long lead times to produce and cleanse proteins and produce a vaccine.Over 150 mRNA vaccines and rehabs are in development worldwide, Roots Analysis stated.

BioNTech had, for years, been establishing a way to battle cancer and get rid of tumors – innovation which they pivoted towards defeating the novel coronavirus.The Pfizer-BioNTech vaccine, called BNT162b2, is based on messenger RNA (mRNA) innovation, which uses a chemical messenger to instruct cells to make proteins that simulate the external surface of the new coronavirus, consequently developing immunity. There has actually been a clear air of vaccine hesitancy – the hesitation or rejection to be immunized – amid world populations, Teluci kept in mind to AP that “no corners were cut” nor stone left unturned while racing to develop a vaccine.”As Teluci noted, the success of COVID-19 vaccines based off of mRNA is smoothing the way for utilizing the novel innovation not just in other vaccines, however potentially as treatments for cystic fibrosis, cancer and other hard-to-treat diseases.Both of the vaccines used by Pfizer-BioNTech and Moderna rely on mRNA technology.Scientists say mRNA has the possible to target illness that can not be reached by traditional drugs.The technology is frequently likened to the operating system on a computer, permitting drugmakers to change their target by inserting new hereditary code into a manufactured type of mRNA, a natural chemical messenger that advises the body to produce particular proteins.Its benefit in vaccines is flexibility and speed compared to standard innovation needing long lead times to produce and cleanse proteins and develop a vaccine.Over 150 mRNA vaccines and therapeutics are in development worldwide, Roots Analysis stated.